RxDoctor Payments Data

Brian Cohen, MD

Orthopaedic Surgery · Chillicothe, OHNPI 1801811096

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $8,648,624 of the $8,760,913 with a category attached, or 98.7%. Arthrex accounts for 99.9% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $2,210,808, 5.4 times the $412,729 reported in 2019. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,760,913in general payments, 2019–2025

Across 135 payments — averaging $64,896 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$8.8M
  • Stryker$2K
  • CDC Medical LLC$1K
  • Johnson & Johnson$300
  • Zimmer Biomet$171
  • Medical Device Business Services, Inc.$150
  • plus $383 from 10 others
$101,815in research payments, 2019–2025

Across 10 payments — averaging $10,182 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$102K

What the payments were for

  • Royalty or licence$8,648,62499%
  • Consulting fees$92,8331%
  • Speaking & faculty fees$13,7350%
  • Travel & lodging$2,3000%
  • Food & beverage$2,1790%
  • Education$1,2430%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,760,913 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.

See all orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$274,883
Medicare patients
349
Services billed
8,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$6,580
Naloxone Hcl72$3,824
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen471$2,908
Linezolid12$1,790
Ondansetron Hcl185$1,078
Cyclobenzaprine Hcl174$835
Diclofenac Sodium13$783
Ketorolac Tromethamine59$751
Methylprednisolone144$729
Doxycycline Hyclate24$678
Gabapentin161$596
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$577
Clindamycin Hcl185$567
Ondansetron OdtOndansetron36$471
Cephalexin108$408

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →